Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

被引:0
|
作者
Kovtun, K. [1 ,2 ]
Moser, J. A. [1 ]
Callery, M. [1 ]
Kent, T. [1 ]
Tseng, J. [1 ]
Miksad, R. [1 ]
Bullock, A. [1 ]
Schlechter, B. [1 ]
Mahadevan, A. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Radiat Oncol Program, Boston, MA USA
关键词
D O I
10.1016/j.ijrobp.2016.06.1090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2486
引用
收藏
页码:E198 / E198
页数:1
相关论文
共 50 条
  • [1] Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer
    Groot, Vincent P.
    Blair, Alex B.
    Gemenetzis, Georgios
    Ding, Ding
    Burkhart, Richard A.
    Yu, Jun
    Rinkes, Inne H. M. Borel
    Molenaar, I. Quintus
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    EJSO, 2019, 45 (09): : 1674 - 1683
  • [2] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Roberto Alva-Ruiz
    Lavanya Yohanathan
    Jennifer A. Yonkus
    Amro M. Abdelrahman
    Lindsey A. Gregory
    Thorvadur R. Halfdanarson
    Amit Mahipal
    Robert R. McWilliams
    Wen Wee Ma
    Christopher L. Hallemeier
    Rondell P. Graham
    Travis E. Grotz
    Rory L. Smoot
    Sean P. Cleary
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
  • [3] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [4] Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy
    Wijetunga, Asanka R.
    Chua, Terence C.
    Nahm, Christopher B.
    Pavlakis, Nick
    Clarke, Stephen
    Chan, David L.
    Diakos, Connie
    Maloney, Sarah
    Ashrafi-Zadeh, Amir
    Kneebone, Andrew
    Hruby, George
    Jamieson, Nigel B.
    Gill, Anthony
    Mittal, Anubhav
    Samra, Jaswinder S.
    EJSO, 2021, 47 (10): : 2543 - 2550
  • [5] Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy
    Barugola, Giuliano
    Partelli, Stefano
    Crippa, Stefano
    Capelli, Paola
    D'Onofrio, Mirko
    Pederzoli, Paolo
    Falconi, Massimo
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (02): : 132 - 139
  • [6] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [7] Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
    Kumar, Rachit
    Jabbour, Salma K.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 353 - 367
  • [8] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [9] Effect of Radiotherapy in Neoadjuvant Treatment of Borderline Resectable and Locally Advanced Pancreatic Cancer
    Tang, Peng
    Zhang, Junfeng
    Zhou, Qiang
    Yi, Wenmin
    Wang, Huaizhi
    PANCREAS, 2025, 54 (03) : e246 - e254
  • [10] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254